ARF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.10960018950834E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.07839999996528E-06 |
Normal-vs-Stage2 |
1.47029999952863E-07 |
Normal-vs-Stage3 |
2.07429629028866E-11 |
Normal-vs-Stage4 |
1.81920001285363E-09 |
Stage1-vs-Stage2 |
1.369920E-02 |
Stage1-vs-Stage3 |
6.219900E-04 |
Stage1-vs-Stage4 |
4.462900E-03 |
Stage2-vs-Stage3 |
9.325800E-01 |
Stage2-vs-Stage4 |
9.646400E-01 |
Stage3-vs-Stage4 |
8.792600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.03959960032307E-10 |
Normal-vs-AfricanAmerican |
9.36489999991963E-08 |
Normal-vs-Asian |
2.713200E-01 |
Caucasian-vs-AfricanAmerican |
2.655400E-01 |
Caucasian-vs-Asian |
2.761200E-01 |
AfricanAmerican-vs-Asian |
1.553800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.10305123210719E-12 |
Normal-vs-Female |
1.51716999999829E-05 |
Male-vs-Female |
3.260000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.16129999999204E-05 |
Normal-vs-Age(41-60Yrs) |
2.74360000274143E-08 |
Normal-vs-Age(61-80Yrs) |
7.99510013749227E-10 |
Normal-vs-Age(81-100Yrs) |
3.242200E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.022000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.477200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.263400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.739200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.572200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.872400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.531400E-01 |
Normal-vs-Grade 2 |
2.61599999995532E-07 |
Normal-vs-Grade 3 |
1.76549996844244E-10 |
Normal-vs-Grade 4 |
1.18630000267572E-08 |
Grade 1-vs-Grade 2 |
8.214200E-02 |
Grade 1-vs-Grade 3 |
2.897600E-02 |
Grade 1-vs-Grade 4 |
1.829590E-02 |
Grade 2-vs-Grade 3 |
9.754400E-02 |
Grade 2-vs-Grade 4 |
2.727600E-02 |
Grade 3-vs-Grade 4 |
3.381400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.56634999999294E-05 |
Normal-vs-ccB subtype |
8.11379963217007E-10 |
ccA subtype-vs-ccB subtype |
1.265920E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.02380000033264E-08 |
Normal-vs-N1 |
9.877500E-02 |
N0-vs-N1 |
7.002200E-01 |
|
|